【Welhunt Technology】Announcement of the Board of Directors' Resolution to Handle Private Placement of Common Shares through Capital Increase
Welhunt Technology's Board of Directors resolved to proceed with a private placement of common shares through capital increase, not exceeding 12,000 thousand shares. This aims to secure strategic investors, invest in proprietary product development and related industry chains, and retain key talent to enhance long-term business development and competitiveness.
📋 Article Processing Timeline
- 📰 Published: May 6, 2026 at 09:00
- 🔍 Collected: May 7, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 7, 2026 at 08:46 (46 min after Collected)
1. Date of Board of Directors' resolution: 115/05/06
2. Type of privately placed securities: Common shares
3. Private placement subscribers and their relationship with the company:
Specific persons who meet the requirements of Article 43-6 of the Securities and Exchange Act and Financial Supervisory Commission Order No. 1120383220 issued on September 12, 112; no subscribers have been identified to date.
(1) If subscribers are company insiders or related parties: Not applicable
(2) Necessity and anticipated benefits if subscribers are strategic investors:
To meet the company's long-term development needs, the introduction of strategic investors will facilitate joint development and business expansion, improve operational performance, and strengthen the company's financial structure and competitiveness.
(3) This private placement is premised on not affecting changes in the company's control.
4. Number of privately placed shares or units:
Limited to a total of no more than 12,000 thousand common shares.
5. Permissible private placement amount:
Limited to a total of no more than 12,000 thousand common shares, to be carried out in 1 to 3 tranches within one year from the date of the shareholders' resolution on this private placement.
6. Basis and rationality of private placement pricing:
(1) The reference price for this private placement of common shares is based on the higher of the following two calculation methods:
(a) The simple arithmetic average of the closing prices of common shares on one of the one, three, or five business days prior to the pricing date, after deducting rights issue ex-dividends and cash dividends, and adding back capital reduction ex-dividends.
(b) The simple arithmetic average of the closing prices of common shares on the thirty business days prior to the pricing date, after deducting rights issue ex-dividends and cash dividends, and adding back capital reduction ex-dividends.
(2) Private placement pricing ratio:
The price per share for this private placement of common shares shall not be less than 80% of the reference price. The pricing date and private placement price shall be determined by the Board of Directors, within the scope of the ratio resolved by the shareholders' meeting, based on future discussions with specific subscribers and market conditions at that time.
(3) The above pricing method is deemed reasonable.
7. Purpose of funds from this private placement:
Each tranche will be used for investing in the development of proprietary products or in upstream/downstream industry chains of proprietary products; and to introduce strategic partners and retain key talent to ensure the company's long-term operational development, thereby enhancing the company's industrial competitiveness.
8. Reasons for not adopting public offering:
To adapt to industry development trends, the company plans to introduce strategic partners and retain key talent to ensure its long-term operational development. Since private placement offers the advantages of rapid and simple fundraising timeliness and restrictions on transfer of privately placed securities, it can better ensure a medium to long-term strategic partnership, thereby enhancing the company's industrial competitiveness. Therefore, fundraising will be conducted via private placement.
9. Independent directors' dissenting or reserved opinions: None
10. Actual pricing date: Undetermined
11. Reference price: Undetermined
12. Actual private placement price, conversion or subscription price: Undetermined
13. Rights and obligations of new shares from this private placement:
The rights and obligations of the common shares from this private placement are, in principle, the same as the company's already issued common shares. However, according to the Securities and Exchange Act, these privately placed common shares may not be resold within three years from the delivery date, except for transfer recipients specified in Article 43-8 of the Securities and Exchange Act. After three years from the delivery date, the Board of Directors is authorized to decide whether to subsequently report public issuance and listing for trading in accordance with relevant regulations, depending on the circumstances at that time.
14. For those with conversion, exchange, or subscription rights, their share conversion base date: Not applicable
15. For those with conversion, exchange, or subscription rights, the potential dilution of equity: Not applicable
16. For those with conversion or subscription rights, the possible impact on the ratio of listed common shares after the private company bonds are delivered and assuming full conversion or subscription to common shares (number of listed common shares A, A/total issued common shares): Not applicable
17. If the number of listed common shares in the preceding item is less than 60 million shares and less than 25%, please explain the countermeasures for low equity liquidity: Not applicable
18. Other matters that should be stated:
(1) Important contents of this private placement of common shares, such as issue price (excluding private placement pricing ratio), issue conditions, issue method, planned use of funds progress, expected possible benefits, and other unmentioned matters, shall be adjusted, determined, and handled by the Board of Directors within the principles and scope of this proposal, subject to authorization by the shareholders' meeting to adapt to market conditions; if changes are necessary due to changes in laws and regulations, amendments by competent authorities, or changes in market conditions in the future, the Board of Directors shall also be authorized by the shareholders' meeting to handle all matters at its discretion in accordance with relevant regulations and authorize the Chairman to sign all contracts and documents related to the private placement of common shares on behalf of the company.
(2) This private placement is premised on not affecting changes in the company's control.
(3) To be submitted for resolution at the ordinary shareholders' meeting on June 24, 115.
2. Type of privately placed securities: Common shares
3. Private placement subscribers and their relationship with the company:
Specific persons who meet the requirements of Article 43-6 of the Securities and Exchange Act and Financial Supervisory Commission Order No. 1120383220 issued on September 12, 112; no subscribers have been identified to date.
(1) If subscribers are company insiders or related parties: Not applicable
(2) Necessity and anticipated benefits if subscribers are strategic investors:
To meet the company's long-term development needs, the introduction of strategic investors will facilitate joint development and business expansion, improve operational performance, and strengthen the company's financial structure and competitiveness.
(3) This private placement is premised on not affecting changes in the company's control.
4. Number of privately placed shares or units:
Limited to a total of no more than 12,000 thousand common shares.
5. Permissible private placement amount:
Limited to a total of no more than 12,000 thousand common shares, to be carried out in 1 to 3 tranches within one year from the date of the shareholders' resolution on this private placement.
6. Basis and rationality of private placement pricing:
(1) The reference price for this private placement of common shares is based on the higher of the following two calculation methods:
(a) The simple arithmetic average of the closing prices of common shares on one of the one, three, or five business days prior to the pricing date, after deducting rights issue ex-dividends and cash dividends, and adding back capital reduction ex-dividends.
(b) The simple arithmetic average of the closing prices of common shares on the thirty business days prior to the pricing date, after deducting rights issue ex-dividends and cash dividends, and adding back capital reduction ex-dividends.
(2) Private placement pricing ratio:
The price per share for this private placement of common shares shall not be less than 80% of the reference price. The pricing date and private placement price shall be determined by the Board of Directors, within the scope of the ratio resolved by the shareholders' meeting, based on future discussions with specific subscribers and market conditions at that time.
(3) The above pricing method is deemed reasonable.
7. Purpose of funds from this private placement:
Each tranche will be used for investing in the development of proprietary products or in upstream/downstream industry chains of proprietary products; and to introduce strategic partners and retain key talent to ensure the company's long-term operational development, thereby enhancing the company's industrial competitiveness.
8. Reasons for not adopting public offering:
To adapt to industry development trends, the company plans to introduce strategic partners and retain key talent to ensure its long-term operational development. Since private placement offers the advantages of rapid and simple fundraising timeliness and restrictions on transfer of privately placed securities, it can better ensure a medium to long-term strategic partnership, thereby enhancing the company's industrial competitiveness. Therefore, fundraising will be conducted via private placement.
9. Independent directors' dissenting or reserved opinions: None
10. Actual pricing date: Undetermined
11. Reference price: Undetermined
12. Actual private placement price, conversion or subscription price: Undetermined
13. Rights and obligations of new shares from this private placement:
The rights and obligations of the common shares from this private placement are, in principle, the same as the company's already issued common shares. However, according to the Securities and Exchange Act, these privately placed common shares may not be resold within three years from the delivery date, except for transfer recipients specified in Article 43-8 of the Securities and Exchange Act. After three years from the delivery date, the Board of Directors is authorized to decide whether to subsequently report public issuance and listing for trading in accordance with relevant regulations, depending on the circumstances at that time.
14. For those with conversion, exchange, or subscription rights, their share conversion base date: Not applicable
15. For those with conversion, exchange, or subscription rights, the potential dilution of equity: Not applicable
16. For those with conversion or subscription rights, the possible impact on the ratio of listed common shares after the private company bonds are delivered and assuming full conversion or subscription to common shares (number of listed common shares A, A/total issued common shares): Not applicable
17. If the number of listed common shares in the preceding item is less than 60 million shares and less than 25%, please explain the countermeasures for low equity liquidity: Not applicable
18. Other matters that should be stated:
(1) Important contents of this private placement of common shares, such as issue price (excluding private placement pricing ratio), issue conditions, issue method, planned use of funds progress, expected possible benefits, and other unmentioned matters, shall be adjusted, determined, and handled by the Board of Directors within the principles and scope of this proposal, subject to authorization by the shareholders' meeting to adapt to market conditions; if changes are necessary due to changes in laws and regulations, amendments by competent authorities, or changes in market conditions in the future, the Board of Directors shall also be authorized by the shareholders' meeting to handle all matters at its discretion in accordance with relevant regulations and authorize the Chairman to sign all contracts and documents related to the private placement of common shares on behalf of the company.
(2) This private placement is premised on not affecting changes in the company's control.
(3) To be submitted for resolution at the ordinary shareholders' meeting on June 24, 115.